The Wellness Company! www.twc.health/glover Code GLOVER Download My Preparedness APP! Watch full video on YouTube
Lucas Miller on May 2, 2026 9:03 pm Nice to see insider buying—usually a good signal in this space. Reply
Emma G. Hernandez on May 2, 2026 9:04 pm Silver leverage is strong here; beta cuts both ways though. Reply
Emma White on May 2, 2026 9:04 pm Interesting update on Russian Nukes and Wellness. Curious how the grades will trend next quarter. Reply
Elijah Williams on May 2, 2026 9:05 pm Nice to see insider buying—usually a good signal in this space. Reply
Jennifer Hernandez on May 2, 2026 9:07 pm If AISC keeps dropping, this becomes investable for me. Reply
Michael Williams on May 2, 2026 9:07 pm Nice to see insider buying—usually a good signal in this space. Reply
Robert Lee on May 2, 2026 9:09 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
William Jones on May 2, 2026 9:10 pm Interesting update on Russian Nukes and Wellness. Curious how the grades will trend next quarter. Reply
Elizabeth Moore on May 2, 2026 9:12 pm Exploration results look promising, but permitting will be the key risk. Reply
Robert Moore on May 2, 2026 9:14 pm Exploration results look promising, but permitting will be the key risk. Reply
Elizabeth W. Thomas on May 2, 2026 9:14 pm Silver leverage is strong here; beta cuts both ways though. Reply
Isabella D. Martin on May 2, 2026 9:15 pm If AISC keeps dropping, this becomes investable for me. Reply
Noah Garcia on May 2, 2026 9:15 pm Interesting update on Russian Nukes and Wellness. Curious how the grades will trend next quarter. Reply
Jennifer Jackson on May 2, 2026 9:18 pm Exploration results look promising, but permitting will be the key risk. Reply
Amelia Thomas on May 2, 2026 9:18 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
43 Comments
Nice to see insider buying—usually a good signal in this space.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Interesting update on Russian Nukes and Wellness. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Nice to see insider buying—usually a good signal in this space.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Russian Nukes and Wellness. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Russian Nukes and Wellness. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.